应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02487 科笛-B
交易中 05-03 13:40:29
7.530
+0.110
+1.48%
最高
7.900
最低
7.500
成交量
12.56万
今开
7.750
昨收
7.420
日振幅
5.39%
总市值
22.95亿
流通市值
22.95亿
总股本
3.05亿
成交额
95.89万
换手率
0.04%
流通股本
3.05亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
科笛-B(02487)股价上升6.334%,现价港币$7.89
阿斯达克财经 · 10:05
科笛-B(02487)股价上升6.334%,现价港币$7.89
科笛-B(02487)股价显著上升10.519%,现价港币$8.09
阿斯达克财经 · 05-02 09:35
科笛-B(02487)股价显著上升10.519%,现价港币$8.09
科笛-B(02487)下跌7.37%,报6.79元/股
金融界 · 04-30
科笛-B(02487)下跌7.37%,报6.79元/股
港股异动 | 科笛-B(02487)涨超8% 治疗脱发产品CU-40102于香港提交新药上市申请
智通财经 · 04-30
港股异动 | 科笛-B(02487)涨超8% 治疗脱发产品CU-40102于香港提交新药上市申请
科笛-B(02487.HK)无锡子公司获江苏省药监局批出生产许可
阿斯达克财经 · 04-30
科笛-B(02487.HK)无锡子公司获江苏省药监局批出生产许可
科笛-B(02487):CU-40102(外用非那雄胺喷雾剂)已在中国香港提交新药上市申请
智通财经 · 04-30
科笛-B(02487):CU-40102(外用非那雄胺喷雾剂)已在中国香港提交新药上市申请
科笛-B(02487):科笛无锡获得药品生产许可证
智通财经 · 04-30
科笛-B(02487):科笛无锡获得药品生产许可证
科笛-B(02487)上涨5.0%,报7.14元/股
金融界 · 04-26
科笛-B(02487)上涨5.0%,报7.14元/股
科笛-B(02487)股价上升5.147%,现价港币$7.15
阿斯达克财经 · 04-26
科笛-B(02487)股价上升5.147%,现价港币$7.15
科笛-B(02487)股价上升7.281%,现价港币$7.22
阿斯达克财经 · 04-22
科笛-B(02487)股价上升7.281%,现价港币$7.22
科笛-B(02487)维持“跑赢行业”评级,目标价12.7港元
中金公司 · 04-19
科笛-B(02487)维持“跑赢行业”评级,目标价12.7港元
科笛-B04月17日主力资金流出16万元 连续3日减仓
自选股智能写手 · 04-17
科笛-B04月17日主力资金流出16万元 连续3日减仓
科笛-B04月16日遭主力抛售57万元 环比增加307.14%
自选股智能写手 · 04-16
科笛-B04月16日遭主力抛售57万元 环比增加307.14%
科笛-B(02487)股价上升7.483%,现价港币$7.9
阿斯达克财经 · 04-09
科笛-B(02487)股价上升7.483%,现价港币$7.9
科笛-B(02487)下跌10.01%,报7.1元/股
金融界 · 04-02
科笛-B(02487)下跌10.01%,报7.1元/股
科笛-B(02487):毛发产品线表现强劲,多管线研发展现中长期成长空间
和讯网 · 04-02
科笛-B(02487):毛发产品线表现强劲,多管线研发展现中长期成长空间
科笛-B(02487)股价显著下跌10.773%,现价港币$7.04
阿斯达克财经 · 04-02
科笛-B(02487)股价显著下跌10.773%,现价港币$7.04
中金:维持科笛-B(02487)“跑赢行业”评级 目标价12.7港元
智通财经 · 04-02
中金:维持科笛-B(02487)“跑赢行业”评级 目标价12.7港元
科笛-B(02487)23年年报点评:优异商业化能力推动毛发&护肤管线持续增长,核心管线获批可期
信达证券 · 03-29
科笛-B(02487)23年年报点评:优异商业化能力推动毛发&护肤管线持续增长,核心管线获批可期
科笛-B(02487.HK)商业化为帆 创新作桨 迈向领先泛皮肤学平台型企业
方正证券 · 03-29
科笛-B(02487.HK)商业化为帆 创新作桨 迈向领先泛皮肤学平台型企业
公司概况
公司名称:
科笛-B
所属市场:
SEHK
上市日期:
--
主营业务:
科笛集团是一家主要从事皮肤学生物药物研发和制造的中国公司。该公司致力于开发全面的解决方案,以满足患者及消费者在广泛皮肤病治疗及护理市场中多样化需求。该公司主要从事其核心产品CU-20401的临床试验。该产品主要用于治疗颏下脂肪堆积。该公司在中国国内市场和海外市场开展其业务。
发行价格:
--
{"stockData":{"symbol":"02487","market":"HK","secType":"STK","nameCN":"科笛-B","latestPrice":7.53,"timestamp":1714714396728,"preClose":7.42,"halted":0,"volume":125600,"delay":0,"floatShares":304738625,"shares":304738625,"eps":-10.418463,"marketStatus":"交易中","marketStatusCode":2,"change":0.11,"latestTime":"05-03 13:40:29","open":7.75,"high":7.9,"low":7.5,"amount":958874,"amplitude":0.053908,"askPrice":7.54,"askSize":16000,"bidPrice":7.5,"bidSize":8400,"shortable":3,"etf":0,"ttmEps":-10.418463012384263,"exchange":"SEHK","tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1714723800000},"adr":0,"listingDate":1686499200000,"adjPreClose":7.42,"openAndCloseTimeList":[[1714699800000,1714708800000],[1714712400000,1714723200000]],"volumeRatio":0.194582,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02487/wiki","defaultTab":"wiki","newsList":[{"id":"2432991168","title":"科笛-B(02487)股价上升6.334%,现价港币$7.89","url":"https://stock-news.laohu8.com/highlight/detail?id=2432991168","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2432991168?lang=zh_cn&edition=full","pubTime":"2024-05-03 10:05","pubTimestamp":1714701900,"startTime":"0","endTime":"0","summary":"[上升股]科笛-B(02487) 股价在上午10:05比前收市价上升6.334%,现股价为港币$7.89。至目前为止,今日最高价为$7.89,而最低价为$7.5。总成交量为9.82万股,总成交金额为港币$74.853万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2405032001/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2432032693","title":"科笛-B(02487)股价显著上升10.519%,现价港币$8.09","url":"https://stock-news.laohu8.com/highlight/detail?id=2432032693","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2432032693?lang=zh_cn&edition=full","pubTime":"2024-05-02 09:35","pubTimestamp":1714613700,"startTime":"0","endTime":"0","summary":"[上升股]科笛-B(02487) 股价在上午09:35比前收市价显著上升10.519%,现股价为港币$8.09。至目前为止,今日最高价为$8.09,而最低价为$8.09。总成交量为5000股,总成交金额为港币$4.045万。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR240502207/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2431413384","title":"科笛-B(02487)下跌7.37%,报6.79元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2431413384","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2431413384?lang=zh_cn&edition=full","pubTime":"2024-04-30 10:57","pubTimestamp":1714445840,"startTime":"0","endTime":"0","summary":"4月30日,科笛-B(02487)盘中下跌7.37%,截至10:57,报6.79元/股,成交1605.19万元。科笛集团是一家专注于皮肤学的生物制药公司,主要业务是研发创新和全面的皮肤病治疗及护理解决方案。公司的目标是成为国际领先的研发型皮肤学平台,为消费者和患者提供创新、安全、有效的皮肤及脱发疾病等全方位的专业解决方案。截至2023年年报,科笛-B营业总收入1.38亿元、净利润-19.64亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/30105740487497.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431388779","title":"港股异动 | 科笛-B(02487)涨超8% 治疗脱发产品CU-40102于香港提交新药上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2431388779","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431388779?lang=zh_cn&edition=full","pubTime":"2024-04-30 10:03","pubTimestamp":1714442587,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,科笛-B(02487)涨超8%,截至发稿,涨8.46%,报7.95港元,成交额1175.14万港元。消息面上,科笛今日宣布,已向中国香港政府卫生署提交CU-40102(外用非那雄胺喷雾剂)新药上市申请(NDA)。据悉,CU-40102是全球首个亦是唯一一个获批用于雄激素性脱发治疗的外用非那雄胺产品,也是首个获得国家药监局受理NDA的外用非那雄胺。开源证券此前指,CU-40102有望成为国内首个外用非那雄胺产品,改良优势明显。方正证券认为,公司重磅管线外用非那雄胺为首家且唯一外用非那雄胺,长期空间有望达15亿+。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1116046.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431504383","title":"科笛-B(02487.HK)无锡子公司获江苏省药监局批出生产许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2431504383","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2431504383?lang=zh_cn&edition=full","pubTime":"2024-04-30 09:18","pubTimestamp":1714439880,"startTime":"0","endTime":"0","summary":"科笛-B(02487.HK) 公布,全资子公司科笛生物医药(无锡)获江苏省药品监督管理局颁发《药品生产许可证》,生产范围为乳膏剂及泡沫剂。科笛无锡本次获得药品生产许可证,预期将对扩大产能及拓展市场产生长远的积极作用,为后续开展候选产品的商业化奠定基础。(cy/w)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20230602115203429_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20230602115203429_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1346183/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2431641876","title":"科笛-B(02487):CU-40102(外用非那雄胺喷雾剂)已在中国香港提交新药上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2431641876","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431641876?lang=zh_cn&edition=full","pubTime":"2024-04-30 07:10","pubTimestamp":1714432218,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科笛-B 公布,该集团的CU-40102新药上市申请已向中华人民共和国香港特别行政区政府卫生署提交。CU-40102是全球首个亦是唯一一个获批用于雄激素性脱发治疗的外用非那雄胺产品,也是首个获得中国国家药品监督管理局受理NDA的外用非那雄胺。与口服非那雄胺不同,CU-40102的外用制剂便于患者将药物直接精确地涂抹在头皮表面,在用药部位保持高浓度,同时可减少口服药常会引起的副作用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1115977.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431887511","title":"科笛-B(02487):科笛无锡获得药品生产许可证","url":"https://stock-news.laohu8.com/highlight/detail?id=2431887511","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431887511?lang=zh_cn&edition=full","pubTime":"2024-04-30 07:02","pubTimestamp":1714431775,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科笛-B(02487)公布,公司的全资子公司科笛生物医药(无锡)有限公司(科笛无锡)获江苏省药品监督管理局颁发《药品生产许可证》。科笛无锡本次获得药品生产许可证,预期将对公司扩大产能及拓展市场产生长远的积极作用,为后续开展候选产品的商业化奠定基础。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1115973.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430217957","title":"科笛-B(02487)上涨5.0%,报7.14元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2430217957","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2430217957?lang=zh_cn&edition=full","pubTime":"2024-04-26 14:32","pubTimestamp":1714113161,"startTime":"0","endTime":"0","summary":"4月26日,科笛-B(02487)盘中上涨5.0%,截至14:32,报7.14元/股,成交280.62万元。科笛集团是一家专注于皮肤学的生物制药公司,主要业务是研发创新和全面的皮肤病治疗及护理解决方案。公司的目标是成为国际领先的研发型皮肤学平台,为消费者和患者提供创新、安全、有效的皮肤及脱发疾病等全方位的专业解决方案。截至2023年年报,科笛-B营业总收入1.38亿元、净利润-19.64亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/26143240426585.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430217836","title":"科笛-B(02487)股价上升5.147%,现价港币$7.15","url":"https://stock-news.laohu8.com/highlight/detail?id=2430217836","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2430217836?lang=zh_cn&edition=full","pubTime":"2024-04-26 14:25","pubTimestamp":1714112700,"startTime":"0","endTime":"0","summary":"[上升股]科笛-B(02487) 股价在下午02:25比前收市价上升5.147%,现股价为港币$7.15。至目前为止,今日最高价为$7.15,而最低价为$6.62。总成交量为37.8万股,总成交金额为港币$256.751万。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2404265208/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2429618399","title":"科笛-B(02487)股价上升7.281%,现价港币$7.22","url":"https://stock-news.laohu8.com/highlight/detail?id=2429618399","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2429618399?lang=zh_cn&edition=full","pubTime":"2024-04-22 09:35","pubTimestamp":1713749700,"startTime":"0","endTime":"0","summary":"[上升股]科笛-B(02487) 股价在上午09:35比前收市价上升7.281%,现股价为港币$7.22。至目前为止,今日最高价为$7.22,而最低价为$7.22。总成交量为3400股,总成交金额为港币$2.457万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2404221000/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2428680501","title":"科笛-B(02487)维持“跑赢行业”评级,目标价12.7港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428680501","media":"中金公司","top":-1,"share":"https://www.laohu8.com/m/news/2428680501?lang=zh_cn&edition=full","pubTime":"2024-04-19 16:16","pubTimestamp":1713514602,"startTime":"0","endTime":"0","summary":"23年公司毛利率同比-18.2ppt至51.6%,主因尚处培育初期、毛利率偏低的护肤品牌欧玛收入占比提升。最终公司净亏损19.64亿元,调整后的经营性净亏损为3.29亿元,净亏损率有所收窄。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404191630288794c07c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404191630288794c07c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428576393","title":"科笛-B04月17日主力资金流出16万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2428576393","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428576393?lang=zh_cn&edition=full","pubTime":"2024-04-17 16:16","pubTimestamp":1713341797,"startTime":"0","endTime":"0","summary":"04月17日, 科笛-B股价跌1.47%,报收6.70元,成交金额139万元,换手率0.07%,振幅6.62%,量比0.75。科笛-B今日主力资金净流出16万元,连续3日净流出,上一交易日主力净流出57万元,今日环比减少71.93%。该股近5个交易日下跌7.45%,主力资金累计净流出86万元;近20日主力资金累计净流入41万元,其中净流入天数为3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171617058787fd2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171617058787fd2a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427981780","title":"科笛-B04月16日遭主力抛售57万元 环比增加307.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427981780","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427981780?lang=zh_cn&edition=full","pubTime":"2024-04-16 16:17","pubTimestamp":1713255424,"startTime":"0","endTime":"0","summary":"04月16日, 科笛-B股价跌1.45%,报收6.80元,成交金额206万元,换手率0.10%,振幅6.23%,量比1.20。科笛-B今日主力资金净流出57万元,上一交易日主力净流出14万元,今日环比增加307.14%。该股近5个交易日下跌7.61%,主力资金累计净流出70万元;近20日主力资金累计净流入124万元,其中净流入天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161618358b2994ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161618358b2994ae&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426871901","title":"科笛-B(02487)股价上升7.483%,现价港币$7.9","url":"https://stock-news.laohu8.com/highlight/detail?id=2426871901","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2426871901?lang=zh_cn&edition=full","pubTime":"2024-04-09 09:35","pubTimestamp":1712626500,"startTime":"0","endTime":"0","summary":"[上升股]科笛-B(02487) 股价在上午09:35比前收市价上升7.483%,现股价为港币$7.9。至目前为止,今日最高价为$7.9,而最低价为$7.19。总成交量为2.4万股,总成交金额为港币$18.036万。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR240409792/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2424056778","title":"科笛-B(02487)下跌10.01%,报7.1元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2424056778","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2424056778?lang=zh_cn&edition=full","pubTime":"2024-04-02 13:39","pubTimestamp":1712036347,"startTime":"0","endTime":"0","summary":"4月2日,科笛-B(02487)盘中下跌10.01%,截至13:39,报7.1元/股,成交317.06万元。科笛集团是一家专注于皮肤学的生物制药公司,主要业务是研发创新和全面的皮肤病治疗及护理解决方案。公司的目标是成为国际领先的研发型皮肤学平台,为消费者和患者提供创新、安全、有效的皮肤及脱发疾病等全方位的专业解决方案。截至2023年年报,科笛-B营业总收入1.38亿元、净利润-19.64亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/02133940090862.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2424487058","title":"科笛-B(02487):毛发产品线表现强劲,多管线研发展现中长期成长空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2424487058","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2424487058?lang=zh_cn&edition=full","pubTime":"2024-04-02 11:57","pubTimestamp":1712030250,"startTime":"0","endTime":"0","summary":"该公司的毛发产品线表现出快速增长,收入占比约为70%。然而,产品结构变化导致公司的毛利率阶段性下降,但规模效应带动净亏损率收窄。此外,该公司多管线研发进展顺利,展现了中长期成长空间。中金看好公司在皮肤管理平台方面的中长期成长空间。总体而言,中金维持了对科笛-B的“跑赢行业”评级,并上调了2024年收入预测。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404021251048ae6dad5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404021251048ae6dad5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424808470","title":"科笛-B(02487)股价显著下跌10.773%,现价港币$7.04","url":"https://stock-news.laohu8.com/highlight/detail?id=2424808470","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2424808470?lang=zh_cn&edition=full","pubTime":"2024-04-02 09:40","pubTimestamp":1712022000,"startTime":"0","endTime":"0","summary":"[下跌股]科笛-B(02487) 股价在上午09:40比前收市价显著下跌10.773%,现股价为港币$7.04。至目前为止,今日最高价为$7.8,而最低价为$6.94。总成交量为8.82万股,总成交金额为港币$63.522万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152742524_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152742524_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD240402600/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2424851150","title":"中金:维持科笛-B(02487)“跑赢行业”评级 目标价12.7港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424851150","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2424851150?lang=zh_cn&edition=full","pubTime":"2024-04-02 09:13","pubTimestamp":1712020381,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,中金发布研究报告称,维持科笛-B“跑赢行业”评级,考虑到公司商业化进程超预期,上调2024年收入预测22%至2.8亿元,维持2025年收入预测;同时考虑到品牌培育期成本及费用投放增加,维持2024-25年盈利预测,目标价12.7港元。最终公司净亏损19.64亿元,调整后的经营性净亏损为3.29亿元,净亏损率有所收窄。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1097532.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2423545424","title":"科笛-B(02487)23年年报点评:优异商业化能力推动毛发&护肤管线持续增长,核心管线获批可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2423545424","media":"信达证券","top":-1,"share":"https://www.laohu8.com/m/news/2423545424?lang=zh_cn&edition=full","pubTime":"2024-03-29 18:17","pubTimestamp":1711707424,"startTime":"0","endTime":"0","summary":"优异商业化能力推动公司毛发&护肤品管线快速放量。在研管线稳步推进,重磅管线获批可期。2023年净亏损部分源自一次性因素影响。港股通持股不断增长,关注度持续提升。考虑到当前港股通出通考核要求为:定期调整考察截至日前12个月月末平均市值低于40亿港元,公司23年7月至24年3月月末平均市值约49亿港元,24年4-6月月末平均市值不低于13.3亿港元即可保在通内,我们预计24年出通概率较小。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403291830288b71d4f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403291830288b71d4f6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2423843925","title":"科笛-B(02487.HK)商业化为帆 创新作桨 迈向领先泛皮肤学平台型企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2423843925","media":"方正证券","top":-1,"share":"https://www.laohu8.com/m/news/2423843925?lang=zh_cn&edition=full","pubTime":"2024-03-29 15:51","pubTimestamp":1711698695,"startTime":"0","endTime":"0","summary":"④未来公司全面的管线布局和深厚的研发储备将驱动公司迈向领先泛皮肤学平台型企业。预计2024-2026年收入约2.83/5.9/10.02亿元,维持“推荐”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403291551408b71230c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403291551408b71230c&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cutiatx.com","stockEarnings":[{"period":"1week","weight":0.0912},{"period":"1month","weight":0.0249},{"period":"3month","weight":0.1415},{"period":"6month","weight":-0.638},{"period":"1year","weight":-0.6604},{"period":"ytd","weight":-0.3242}],"compareEarnings":[{"period":"1week","weight":0.0534},{"period":"1month","weight":0.0753},{"period":"3month","weight":0.1721},{"period":"6month","weight":0.0307},{"period":"1year","weight":-0.0757},{"period":"ytd","weight":0.068}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"科笛集团是一家主要从事皮肤学生物药物研发和制造的中国公司。该公司致力于开发全面的解决方案,以满足患者及消费者在广泛皮肤病治疗及护理市场中多样化需求。该公司主要从事其核心产品CU-20401的临床试验。该产品主要用于治疗颏下脂肪堆积。该公司在中国国内市场和海外市场开展其业务。","exchange":"SEHK","name":"科笛-B","nameEN":"CUTIA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科笛-B(02487)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科笛-B(02487)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科笛-B,02487,科笛-B股票,科笛-B股票老虎,科笛-B股票老虎国际,科笛-B行情,科笛-B股票行情,科笛-B股价,科笛-B股市,科笛-B股票价格,科笛-B股票交易,科笛-B股票购买,科笛-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科笛-B(02487)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科笛-B(02487)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}